GLP-1 and Liver Health: What UK Patients Should Know (October 2026)

01 · The core answer

Is Mounjaro hard on your liver?

Mounjaro is not known to damage the kidneys or liver directly, and no dose adjustment is needed for mild to moderate kidney or liver impairment.¹

The practical risk the product information points to is indirect. Severe vomiting or diarrhoea can cause dehydration, which can strain the kidneys, so keep fluids up and get medical help straight away if you cannot keep fluids down.¹ That is a kidney point rather than a liver one, but it is worth knowing because the two organs are often discussed together.

You will see headlines about GLP-1 medicines and liver health. But research is not the same as a licensed use. For our detailed look at the evidence question, see our guide on whether Mounjaro helps your liver.

02 · Your decision

What this means if you have a liver condition

If you have fatty liver, a liver condition or abnormal liver tests, the useful question is not "is this medicine toxic to my liver?" but "is treatment suitable for me, and who should oversee it?" Tell the prescriber everything in your consultation. Your full medical history and medicine list matter, because suitability is an individual judgement.¹

Our weight loss clinic consultation is free and reviewed by a GPhC-registered prescriber.

03 · What the label says

What the product information says about the liver

Mounjaro is not known to damage the kidneys or liver directly. No dose adjustment is needed for mild to moderate impairment. People with severe impairment need individual prescriber assessment.¹

Three things follow from that. First, there is no routine liver warning that applies to everyone. Second, the medicine is not removed from the table for people with mild or moderate liver problems. Third, severe disease is handled case by case rather than by a blanket rule.

It does not say that Mounjaro treats liver disease. Nor does it say the opposite. It is simply silent on liver benefit, because the licensed uses are weight management and type 2 diabetes.¹

If you want the same topic in a more technical framing, our page on Mounjaro and liver function goes through it, and the patient leaflet is the document to read for the full wording.¹³

04 · Fatty liver and weight

Fatty liver, weight and GLP-1 research

Fatty liver is closely tied to excess weight and to how the body handles sugar and fat. That is why so many people with it are told to lose weight. Weight management is the licensed purpose of Mounjaro, so the two topics naturally overlap.¹

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages, and individual results vary.

For someone starting at 100 kg, 20.9% is about 21 kg.

In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.¹ These are trial-average secondary outcomes, not promises.

Semaglutide, the medicine in Wegovy, is the other well-known GLP-1 treatment, and it has its own trial record in weight management.⁹

05 · Research versus licence

Research is not the same as a licence

Reading a research abstract about liver scarring or inflammation is not the same as being prescribed a medicine for it. A licence is granted for a specific condition, based on specific evidence, with specific safety monitoring. Mounjaro's UK licence covers weight management in adults and type 2 diabetes.¹

Studies in this area often use particular patient groups, particular doses and close specialist follow-up. Their findings may not carry over to someone buying a weight-loss medicine through an online pharmacy. That is not a criticism of the research. It is a reason to base any decision on the licensed uses, not on liver research.

Be wary of anyone who sells a GLP-1 medicine as a "liver cure", or who offers to supply without a consultation or prescription. A genuine supplier will ask about your liver history, not skip it. Report suspected counterfeit products through the Yellow Card scheme.⁷

Our related guide on GLP-1 and liver issues covers the same ground from the problem side, and Mounjaro and your liver is the shorter version.

06 · Symptoms to act on

Liver pain and symptoms: when to seek help

Pain in the upper right abdomen, fever or yellowing of the skin or eyes needs medical help straight away, as these can be signs of gallbladder problems.¹ People often call this "liver pain" because of where it sits, but the gallbladder is next door, and the product information flags it specifically.

Severe, persistent stomach pain that may spread to your back, with or without vomiting, is a possible sign of pancreatitis and also needs medical help straight away.¹ Do not wait to see whether it settles. Seek immediate medical help for signs of a severe allergic reaction, such as swelling of the face or throat and difficulty breathing.

Mild nausea, constipation or loose stools in the early weeks are different. They are common with this class of medicine and are not liver symptoms. If they become severe and you cannot keep fluids down, contact your clinical team, because dehydration is the indirect risk to watch.¹

If a new symptom worries you, speak to a doctor or call NHS services. You can also report it to the MHRA through the Yellow Card scheme.¹⁹

07 · Cirrhosis and liver failure

Cirrhosis, fibrosis and liver failure

Severe liver impairment is the group where the product information asks for individual prescriber assessment.¹ Advanced scarring (cirrhosis) and liver failure would normally fall into that group. Your own liver specialist knows your condition far better than any online form can capture.

In practice, that means two things. If you are under a hepatology or gastroenterology team, talk to them before applying for any weight-loss medicine, and bring their view to your consultation. And if you are told you have significant scarring on a scan or test, do not assume a standard online route is right for you.

Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.

Early fibrosis, mild fatty liver or mildly abnormal tests sit in a different place. The label does not rule these out, and the prescriber will weigh them with the rest of your history. See also our page on whether Mounjaro can affect liver function.

08 · Other conditions to declare

Related conditions your prescriber will ask about

Liver trouble often travels with other health issues, and several of them matter for suitability. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems.¹³

Mounjaro should not be used during pregnancy or while trying to conceive, and you should not take it if you are allergic to tirzepatide or any of its ingredients.¹³ Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. If you take insulin or a sulfonylurea, watch for low blood sugar (shakiness, sweating, confusion), as your prescriber may need to adjust those medicines.¹

Tell your prescriber if you or a close relative have had medullary thyroid cancer or the inherited condition MEN 2.¹ Routine thyroid monitoring is not required for most people.

Being complete in the consultation is the single most useful thing you can do. A full medicine list matters too, including anything you take for your liver or bought without a prescription.

09 · How it is processed

How the body clears the medicine

Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹ If you stop because of a liver concern, expect the medicine to remain present for some time, and tell your clinician.

It works by activating two natural gut-hormone receptors, GIP and GLP-1, which help regulate appetite, slow how quickly the stomach empties and improve how the body responds to insulin.¹

Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed. The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹

10 · NHS and private routes

NHS and private routes if you have liver disease

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴ Full rollout is expected to take years.

If you have a liver condition, your NHS team may be best placed to decide, because they can see your scans, blood tests and specialist letters. Ask your GP what is available locally.⁶

Many people who meet the licensed criteria choose regulated private treatment rather than waiting. If you do, look for a pharmacy on the GPhC register. Ours is GPhC 9012878, and supply is official LillyDirect stock, sourced directly from Eli Lilly.¹² The consultation is free, and ongoing monthly reviews are included.